IRB e-Mail Archives 2005

View e-mails from 2000 and 2001 View e-mails from 2002 View e-mails from 2003 and 2004 View e-mails from 2006 View e-mails from 2007
Date	Subject
Dec 9, 2005	Ask the IRB for Exempt/Expedited Studies – 12/21/05 - CANCELED REMINDER: Conflict of Interest (COI) Presentation – 12/12/05
Dec 7, 2005	Conflict of Interest (COI) Presentation New Guidance on IRB Web site Ask the IRB Ask the IRB for Exempt/Expedited Studies
Nov 28, 2005	Deadlines and IRB Meeting Dates IRB Office Hours Ask the IRB Ask the IRB for Exempt/Expedited Studies Clinical Trials Office Position
Nov 4, 2005	Holidays and Renewals "Ask the IRB" for Exempt and Expedited Studies – Wednesday, November 16, 2005
Oct 28, 2005	"Ask the IRB" – Tuesday, November 1, 2005 "Ask the IRB" for Exempt and Expedited Studies – Wednesday, November 16, 2005
Oct 5, 2005	Revisions on IRB Web Site "Ask the IRB" for Exempt and Expedited Studies – Wednesday, October 19, 2005
Oct 3, 2005	"Ask the IRB" – Tuesday, October 4, 2005 – Topic: Unanticipated Problems
Sept 19, 2005	Study Terminations Re-Submitting a Study Previously Approved/Submitted to the IRB "Ask the IRB" for Exempt & Expedited Studies – Wednesday, September 21, 2005
Sept 7, 2005	New Human Subjects Protection module is now available for researchers in the Social and Behavioral Sciences Clinical Trial Registration Deadline "Ask the IRB" for Exempt & Expedited Studies – Wednesday, September 21, 2005
Aug 19, 2005	Renewals of IRB Submissions Presentation – Top Ten Reasons for IRB Reconsiderations Full Board Committee Meetings Clinical Trials Office – Open Position
Aug 16, 2005	"Ask the IRB" for Exempt & Expedited Studies: Aug 17, 2005 Registries and Tissue Banks New IRB Cover Sheet
July 22, 2005	IRB Members Needed OHRP International Compilation of Human Subject Research Protections Industry-Sponsored Fee Information Forms
July 21, 2005	Studies Involving Mifeprex (mifepristone) – Immediate Action Studies Involving Raptiva (efalizumab) – Immediate Action Required
July 18, 2005	Studies Involving Sustiva (efavirenz) – Immediate Action Required
July 18, 2005	Studies Involving Palladone (hydromorphone hydrochloride, extended release capsules) – Immediate Action Required
July 15, 2005	Studies Involving Duragesic (fentanyl transdermal system) – Immediate Action Required “Ask the IRB” for Exempt and Expedited Studies
July 1, 2005	Full Board Committee Changes
June 20, 2005	Responding to Comments and Modifications Recruitment from Research Registries Atypical Antipsychotics and Mortality in the Elderly: Suggested Language for Protocols and Consent Documents Chart for Maximum Allowable Blood Draw Volumes
June 16, 2005	Studies Involving Novantrone (mitoxantrone) – Immediate Action Required Studies Involving Natrecor (nesiritide) – Immediate Action Required
June 9, 2005	Industry-Sponsored Studies and Fees Conflict of Interest Information “Ask the IRB” for Exempt and Expedited Studies IRB Office Closed for Staff Development
May 6, 2005	And the Winner is… Consent for Children in Research (Foster Children and Emancipated Minors) Retrospective Medical Record Reviews "Ask the IRB" for Exempt & Expedited Studies Registration for the Research Coordinator Orientation Seminar
April 22, 2005	A message from Christopher Ryan, Director of the IRB Ask the IRB - Topic: New IRB Guidance for Research Limited to Retrospective Medical Record Reviews
April 19, 2005	Studies Involving BEXTRA (valdecoxib) – Immediate Action Required
April 15, 2005	GCRC Protocol Formats for IRB Submissions Who to Contact at the IRB with Specific Questions Upcoming “Ask the IRB” for Exempt and Expedited Studies Clarification of the Pitt Research Network Mailing List Clinical Trials Office Announcement
Feb 11, 2005	Coordinating Center Guidance - New IRB Appendix IRB Workshop for Exempt & Expedited Studies "Ask the IRB"
Jan 13, 2005	AAHRPP - Accreditation of the Univ of Pittsburgh IRB and Human Research Protection Programs

Institutional Review Board

IRB e-Mail Archives 2005